Naslov
Assessment of cutaneous toxcitiy in cancer patients treated with CDK 4/6 inhibitors and endocrine therapy according to patient-related outcomes at the University Hospital for tumors

Autori
Jakšić, Petra ; Linarić, Petra ; Jezernik, Dejana ; Kanceljak, Kristina ; Tečić Vuger, Ana ; Pavlović Mavić, Mirjana ; Vazdar, Ljubica ; Šeparović, Robert

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Libri Oncologici : Croatian Journal of Oncology / - , 2022, 88-89

Skup
15. HRVATSKI ONKOLOŠKI KONGRES

Mjesto i datum
Opatija, Hrvatska, 31.03.2022. - 03.04.2022

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
CDKi, cutaneous toxicity, rash

Sažetak
Cyclin-dependent kinases 4/6 inhibitors (CDKi), abemaciclib, ribociclib, and palbociclib, along with endocrine therapy are standard of care in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer.This specific therapy improves treatment outcomes for this defined population adjacent to a manageable toxicity profile. This analysis of real-life clinical practice has asserted that cutaneous toxicity is prevalent in this observed population also announced the requirement for enhanced compassion of symptoms experienced by patients on this specific treatment.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA